🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate the safety and efficacy of inavolisib combination ...
Status
Recruiting
Location
Los Angeles Cancer Network
Start Date
2025-09-09
Trial ID
NCT07054190
Treatments Being Tested
This study is a prospective, open-label, multicenter, randomized controlled...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-06-15
Trial ID
NCT07005557
Treatments Being Tested
This study is a multicenter, single-arm, open-label Phase II exploratory cl...
Status
Recruiting
Location
Breast surgery department
Start Date
2026-01-07
Trial ID
NCT07380646
Treatments Being Tested
The goal of this clinical trial is to compare trastuzumab deruxtecan (T-DXd...
Status
Recruiting
Location
Skåne University Hospital
Start Date
2023-10-26
Trial ID
NCT05900206
Given the uncertain benefit in efficacy of adding CDK 4/6 to first rather t...
Status
Active Not Recruiting
Location
Jeroen Bosch Ziekenhuis
Start Date
2017-11-09
Trial ID
NCT03425838
Treatments Being Tested
This phase 3 clinical trial compares the efficacy and safety of palazestran...
Status
Recruiting
Location
Clinical Trial Site
Start Date
2025-11-03
Trial ID
NCT07085767
Treatments Being Tested
The purpose of this open-label, multicenter, phase IIIb, single-arm study i...
Status
Recruiting
Location
Central Alabama Research
Start Date
2024-02-28
Trial ID
NCT05827081
Treatments Being Tested
This was a randomized, double-blind, placebo-controlled study conducted in ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2018-08-29
Trial ID
NCT03671330
Treatments Being Tested
Aromatase inhibitor (AI) + CDK4/6 inhibitor is settled down as the standard...
Status
Recruiting
Location
Korea university Guro hospital
Start Date
2023-05-31
Trial ID
NCT05816655
Treatments Being Tested
This prospective, observational, multicenter study aims at evaluating the e...
Status
Recruiting
Location
Novartis Investigative Site
Start Date
2025-12-03
Trial ID
NCT06930859
Treatments Being Tested